Top

Internal and Emergency Medicine

Published in:

01-03-2021 | Oral Anticoagulant | CE - LETTER TO THE EDITOR

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment

Authors: Loris Roncon, Marco Zuin, Gianluca Rigatelli

Published in: Internal and Emergency Medicine | Issue 2/2021

Excerpt

Dear Editor, …

Testa S, Paoletti O, Giorgi-Pierfranceschi M, Pan A (2020) Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients. Intern Emerg Med. https://doi.org/10.1007/s11739-020-02331-1CrossRefPubMedPubMedCentral

Lippi G, Plebani M, Henry BM (2020) Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 506:145–148CrossRef

Yang X, Yang Q, Wang Y, Wu Y, Xu J, Yu Y, Shang Y (2020) Thrombocytopenia and its association with mortality in patients with COVID-19. J Thromb Haemost. https://doi.org/10.1111/jth.14848CrossRefPubMedPubMedCentral

Amgalan A, Othman M (2020) Exploring possible mechanisms for COVID-19 induced thrombocytopenia: unanswered questions. J Thromb Haemost. https://doi.org/10.1111/jth.14832CrossRefPubMedPubMedCentral

Title: Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
Authors: Loris Roncon
Marco Zuin
Gianluca Rigatelli
Publication date: 01-03-2021
Publisher: Springer International Publishing
Keywords: Oral Anticoagulant
Thrombocytopenia
COVID-19
Heparin
Published in: Internal and Emergency Medicine / Issue 2/2021
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-020-02358-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2021

Influence of ventilatory strategies on outcomes and length of hospital stay: assist control and synchronized intermittent mandatory ventilation modes

Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis

Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis

Ferric carboxymaltose for sub-acute and chronic iron deficiency anemia in inherited platelet function defects

COVID-19, coagulopathy and venous thromboembolism: more questions than answers—comment

Intravitreal anti‑VEGF agents and cardiovascular risk: comment

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials